3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
4
Unknown
3
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
7
Osteosarcoma
4
Lymphoma
3
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Gliosarcoma
2
Glioblastoma
2
Gastrointestinal Stromal Tumors
2
Dendritic Cell Sarcoma, Interdigitating
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Leukemia
1
Histiocytic Sarcoma
1
Glioma
1
Gallbladder Neoplasms
1
Eyelid Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Interventions
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Drug-Related Side Effects and Adverse Reactions
×
Sarcoma
×
Clear all
NCT04824352
2024-05-14
AIEO
Peking University People's Hospital
Phase 2
Suspended
44 enrolled